Skip to main content

Orthocell receives US approval for Remplir

04/04/2025 - 08:04

Bookmark

Save articles for future reference.

Orthocell has received clearance from the US-based Food and Drug Administration to begin selling its nerve repair product Remplir in the country.

X

To read our articles you will need to either login or subscribe.